MktsMarkets

Aura Biosciences, Inc.
NASDAQ: AURAKey statistics
AURA News
Stories mentioning AURA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 27,960 | 21,897 | 22,178 | 22,882 | 23,343 | 22,335 | 17,036 | 16,879 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (34,866) | (27,237) | (27,906) | (28,613) | (29,035) | (27,809) | (23,232) | (22,762) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 2.00 | 150.00 | (13.00) | (36.00) | (24.00) | (37.00) | (25.00) | (26.00) |
| Pretax Income | (33,674) | (25,543) | (26,104) | (26,971) | (27,465) | (25,811) | (20,999) | (20,337) |
| Tax Provision | 11.00 | 16.00 | 26.00 | 48.00 | 18.00 | 43.00 | ||
| Net Income (Loss) | (33,685) | (25,559) | (26,130) | (27,019) | (27,483) | (25,834) | (21,042) | (20,337) |
| Earnings Per Share (Basic) | (0.50) | (0.42) | (0.40) | (0.47) | (0.55) | (0.52) | (0.42) | (0.41) |
| Earnings Per Share (Diluted) | (0.50) | (0.42) | (0.40) | (0.47) | (0.55) | (0.52) | (0.42) | (0.41) |
| Weighted Average Shares Outstanding (Basic) | 67,448 | 60,338 | 65,937 | 58,016 | 50,126 | 49,650 | 49,664 | 49,548 |
| Weighted Average Shares Outstanding (Diluted) | 67,448 | 60,338 | 65,937 | 58,016 | 50,126 | 49,650 | 49,664 | 49,548 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About AURA
Aura Biosciences, Inc. (NASDAQ: AURA) is a stock listed on the Nasdaq Stock Market under the ticker symbol AURA. It last traded at $6.87 (Nov 20, 2026, 4:00 PM ET), down 1.6% on the day. That gives Aura Biosciences a market capitalisation of $726.4M.
Over the past 52 weeks AURA has traded between $4.73 and $9.54.
For the quarter ended Mar 31, 2026 it reported a net loss of $33.7M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$33.7M |
| Dec 31, 2025 | — | -$25.6M |
| Sep 30, 2025 | — | -$26.1M |
| Jun 30, 2025 | — | -$27.0M |
From Aura Biosciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…